Post-approval studies (Phase 4)Study completedNCT04833101
What this trial is testing
Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine
Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 120